Douglas J. Hartman

Biochemistry, Genetics and Molecular BiologyComputer ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial”.

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial

Cancer Cell(2024)10.1016/j.ccell.2024.10.007

N/A

1.3DataRank · unranked

59 citations

Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joë-Marc Chauvin, F. Amatore +48 more

Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad535

N/A

0.542DataRank · unranked

17 citations

Ian McGowan, Peter A. Anton, Edward J. Fuchs, Ken Ho, Alex Carballo‐Diéguez +20 more

SPaRTAN, a computational framework for linking cell-surface receptors to transcriptional regulators

Nucleic Acids Research(2021)10.1093/nar/gkab745

N/A

0DataRank · unranked

16 citations

Ashwin Somasundaram, Zengbiao Qi, Douglas J. Hartman, Harinder Singh, Hatice U. Osmanbeyoglu +1 more

Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival

Gastroenterology(2022)10.1053/j.gastro.2022.08.025

N/A

0DataRank · unranked

40 citations

Imon Banerjee, Sameer Shivji, Suchit Jain, Douglas J. Hartman, Daniel D. Buchanan +20 more

605 Neoadjuvant vidutolimod (vidu) and nivolumab (nivo) results in MPR and immune activation in high-risk resectable melanoma (MEL): final phase II clinical trial results

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0605

N/A

0DataRank · unranked

4 citations

Joë-Marc Chauvin, Robert Morrison, Yulong Bai, Jie Sun, Hong Wang +22 more

Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma

Research Square(2022)10.21203/rs.3.rs-2235839/v1

N/A

0DataRank · unranked

1 citations

Arivarasan Karunamurthy, Joë-Marc Chauvin, Robert M. Morrison, Yulong Bai, Jie Sun +40 more

Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.09.275

N/A

0DataRank · unranked

15 citations

Xuanye Cao, Neus Bota-Rabassedas, Beatriz Sanchez-Espiridion, Sabina Berezowska, Yuchen Han +20 more

Value of Public Challenges for the Development of Pathology Deep Learning Algorithms

Journal of Pathology Informatics(2020)10.4103/jpi.jpi_64_19

N/A

0DataRank · unranked

44 citations

Jeroen van der Laak, Metin N. Gürcan, Liron Pantanowitz, Douglas J. Hartman

Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technology (MTN-037)

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003506

N/A

0DataRank · unranked

0 citations

Craig Hoesley, Peter L. Anderson, José A. Fernández-Romero, Barbara Friedland, Clifton W. Kelly +21 more

Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer

EBioMedicine(2021)10.1016/j.ebiom.2021.103347

N/A

0DataRank · unranked

22 citations

Chad Storer, Uma Chandran, William A. LaFramboise, Patricia Petrosko, Madison Frank +6 more